James S. Manuso, PhD, MBA
Chief Transaction Advisor
Dr. James S. Manuso is a seasoned CEO and serial entrepreneur in the biotech and pharmaceutical industry. With extensive experience in founding, managing, and selling companies, he has executed deals exceeding $2 billion. Currently CEO of Talfinium Investments Inc., Dr. Manuso serves on the boards of Ocuphire (NASDAQ:OCUP) and Morphogenesis, Inc. Previously, he led Astex Pharmaceuticals to a successful sale to Otsuka for $886M and spun out technology for Tolero Pharmaceuticals, acquired for up to $780M. Dr. Manuso’s career includes key roles in PrimeTech Partners, The Channel Group LLC, and various boards. He holds advanced degrees from prestigious institutions, including a Ph.D. and Executive MBA.